5,404 Shares in U.S. Physical Therapy, Inc. (NYSE:USPH) Purchased by AlphaCentric Advisors LLC

AlphaCentric Advisors LLC purchased a new stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 5,404 shares of the company's stock, valued at approximately $479,000.

Several other institutional investors have also added to or reduced their stakes in the company. State Street Corp raised its stake in shares of U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company's stock worth $56,522,000 after acquiring an additional 99,244 shares in the last quarter. Copeland Capital Management LLC raised its position in shares of U.S. Physical Therapy by 9.5% in the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock worth $74,459,000 after acquiring an additional 72,715 shares during the period. Southernsun Asset Management LLC lifted its position in shares of U.S. Physical Therapy by 10.5% during the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company's stock valued at $46,302,000 after buying an additional 52,062 shares in the last quarter. Penn Davis Mcfarland Inc. acquired a new stake in U.S. Physical Therapy in the 3rd quarter worth about $2,552,000. Finally, Rockefeller Capital Management L.P. lifted its holdings in U.S. Physical Therapy by 18.8% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company's stock valued at $13,578,000 after purchasing an additional 25,393 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages have commented on USPH. JPMorgan Chase & Co. lifted their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 3rd. Citizens Jmp raised shares of U.S. Physical Therapy to a "strong-buy" rating in a report on Monday, December 16th. JMP Securities started coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They set an "outperform" rating and a $113.00 price objective for the company. Bank of America upgraded shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. Finally, Barrington Research restated an "outperform" rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, U.S. Physical Therapy currently has an average rating of "Buy" and a consensus price target of $114.00.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH traded down $1.87 during trading on Thursday, hitting $86.10. 54,444 shares of the company were exchanged, compared to its average volume of 84,998. The firm's fifty day moving average price is $89.21 and its 200 day moving average price is $87.82. The company has a market cap of $1.30 billion, a price-to-earnings ratio of 91.59, a PEG ratio of 3.64 and a beta of 1.48. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now directly owns 20,469 shares of the company's stock, valued at $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.70% of the stock is currently owned by insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.